Acute Graft Versus Host Disease - 162 Studies Found

Withdrawn : Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease
: Graft Versus Host Disease
: 2012-06-07
:
  • Drug: brentuximab vedotin Give
Terminated : Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
:
  • Hematological Malignancies
  • Myelodysplastic Syndrome
  • Leukem
    : 2007-07-20
    :
    • Drug: Mycophenolate Mofetil (MMF)

Completed : Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease
: Graft Versus Host Disease
: 2012-01-23
:
  • Biological: Alpha-1-Proteinase Inhibitor Human

Active, not recruiting : Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)
: Leukemia
: 2012-05-23
: Drug: low-dose glucocorticoid Methylprednisolone patients receive low-dose glucocorticoid from day 5 pos
Recruiting : Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
:
  • Graft-versus-host Disease
  • Poor Graft Function
  • Low Donor T-
    : 2008-01-16
    : Biological: Mesenchymal stem cells Mesenchymal Stem Cell infusion
Completed : Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
: Malignant Neoplasm
: 2012-01-31
:
  • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed : Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant
:
  • AML
  • ALL
  • Undifferentiated Leukemia
  • Hematopoietic/Lymphoid Cancer
  • Accelerated Phase Chronic Myelogenous Leukemia
  • : 2007-06-20
    :
    • Drug: beclomethasone dipropionate

Recruiting : Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
: Graft vs Host Disease
: 2015-03-24
:
  • Biological: Begelomab BEGEDINA
Recruiting : Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD
: Graft vs Host Disease
: 2014-01-03
: Biological: T-Guard Other Name: Combination of SPV-T3a-RTA and WT1-RTA (equal parts, w/w)
<<< Previous | Next >>>